Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Breast Neoplasms 11Lung Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Rectal Neoplasms 4Colorectal Neoplasms 4Colonic Neoplasms 4Carcinoma, Ovarian Epithelial 4Carcinoma, Intraductal, Noninfiltrating 4Breast Carcinoma In Situ 4Brain Neoplasms 4Unspecified Adult Solid Tumor, Protocol Specific 3Squamous Cell Carcinoma of Head and Neck 3Prostatic Neoplasms 3Ovarian Neoplasms 3Liver Neoplasms 3Head and Neck Neoplasms 3Carcinoma, Hepatocellular 3Salivary Gland Neoplasms 2Precancerous Conditions 2Pancreatic Neoplasms 2Neoplasm Metastasis 2Gliosarcoma 2Glioblastoma 2Esophageal Neoplasms 2Central Nervous System Neoplasms 2Carcinoma, Renal Cell 2Adenocarcinoma Of Esophagus 2Waldenstrom Macroglobulinemia 1Urinary Bladder Neoplasms 1Urethral Neoplasms 1

Interventions

Temozolomide 16Magnetic Resonance Spectroscopy 10Etoposide 9Cyclophosphamide 8Radiotherapy 7Carboplatin 7Bevacizumab 7Filgrastim 6Thiotepa 5Radiation 4Biopsy 4Azacitidine 42-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 4sargramostim 3etoposide phosphate 3Surveys and Questionnaires 3Peripheral Blood Stem Cell Transplantation 3Nivolumab 3Methotrexate 3Irinotecan 3Gadolinium DTPA 3Cisplatin 3Automobiles 3lutetium Lu 177 dotatate 2fluorodopa F 18 2alovudine 2aldesleukin 2Yoga 2Topotecan 2Thalidomide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Ependymoma × Mass Spectrometry × Clear all
NCT01234740 2018-04-17

Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases

City of Hope Medical Center

Phase 1 Completed
7 enrolled
CNSSarcoma

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡